Front Desk: 469-391-0070
Pterygium: Causes, Symptoms, and Effective Treatment Options
Introduction
Pterygium, often referred to as “surfer’s eye,” is a common eye condition, particularly in areas with high exposure to sunlight. It is a benign growth of tissue on the sclera (the white part of the eye) that can extend onto the cornea. Although non-cancerous, it can cause discomfort and, in more severe cases, impair vision. Historically, pterygium has been more prevalent among individuals who spend significant time outdoors, especially in sunny, windy, or dusty environments.
This article aims to provide a comprehensive understanding of pterygium, including its risk factors, symptoms, diagnosis, and treatment options. We will also explore home remedies and preventive measures to help manage symptoms and prevent the condition from worsening.
What is Pterygium?
Pterygium is a fibrovascular growth on the eye that can lead to discomfort and vision problems. This article will delve into its risk factors, symptoms, diagnostic tests, medications, procedures, and home remedies to help manage the condition.
Description of Pterygium
Pterygium is a wedge-shaped growth that begins on the conjunctiva (the clear tissue covering the white part of the eye) and can extend onto the cornea (the transparent front surface of the eye). The condition is typically slow-growing and varies in size. In some cases, it remains small and causes no significant issues, while in others, it can grow large enough to interfere with vision by covering the cornea.
The progression is generally gradual. In the early stages, it may appear as a small, pinkish or red bump on the white of the eye. Over time, it can enlarge, causing symptoms such as irritation, redness, dryness, and a sensation of something in the eye. In more advanced cases, the growth can distort the cornea, leading to astigmatism or blurred vision.
Research indicates that pterygium is more common in individuals living in areas with high ultraviolet (UV) exposure, such as tropical and subtropical regions. Studies estimate its prevalence ranges from 1% to 33% in different populations, with higher rates among those frequently exposed to sunlight without adequate eye protection.
Risk Factors for Developing Pterygium
Lifestyle Risk Factors
Several lifestyle factors can increase the risk of developing pterygium. Prolonged exposure to ultraviolet (UV) light is one of the most significant. People who spend a lot of time outdoors, especially in sunny climates, are at higher risk. This includes individuals working in agriculture, fishing, or construction, as well as those participating in outdoor sports like surfing or skiing.
Exposure to environmental irritants such as wind, dust, and sand also contributes to pterygium development. These elements can irritate the eye’s surface, leading to inflammation and promoting abnormal tissue growth. Wearing protective eyewear, such as UV-blocking sunglasses, can help reduce the risk in these environments.
Medical Risk Factors
Certain medical conditions may increase the likelihood of developing pterygium. Chronic dry eye syndrome, for example, is associated with a higher risk. When the eyes do not produce enough tears or the tears evaporate too quickly, the eye’s surface becomes irritated, contributing to pterygium formation.
Inflammatory eye conditions, such as conjunctivitis (inflammation of the conjunctiva), may also play a role. Repeated episodes of inflammation can damage the conjunctiva, making it more susceptible to abnormal tissue growth.
Genetic and Age-Related Risk Factors
Genetics may also influence pterygium development. Some studies suggest that individuals with a family history of pterygium are more likely to develop the condition, possibly due to inherited traits affecting the eye’s surface structure or function.
Age is another important factor. Pterygium is more common in people over 40, although it can occur in younger individuals with significant UV exposure. As we age, the eye becomes more vulnerable to environmental stressors, and the body’s ability to repair damage to the eye’s surface decreases, making pterygium formation more likely.
Pterygium Symptoms and Clinical Manifestations
Redness
Occurrence: Redness is one of the most common symptoms, affecting 70-80% of patients, especially in the early stages when the pterygium is actively growing.
Explanation: Redness occurs due to inflammation of the conjunctiva. As the pterygium grows, it irritates surrounding tissues, causing blood vessels to dilate, leading to a red or bloodshot appearance. Environmental factors like wind, dust, or UV exposure can exacerbate this symptom.
Irritation
Occurrence: About 60-70% of patients experience irritation, particularly those frequently exposed to harsh environmental conditions, such as outdoor workers.
Explanation: Irritation is caused by the pterygium’s physical presence on the eye’s surface. As it extends onto the cornea, it disrupts the smooth surface, leading to discomfort. Inflammation from the growth further contributes to this sensation.
Foreign Body Sensation
Occurrence: Approximately 50-60% of patients report a foreign body sensation, especially as the pterygium enlarges.
Explanation: This sensation occurs when the pterygium encroaches on the cornea, creating an uneven surface. This irregularity makes it feel like something is in the eye, even though no external object is present. Blinking often aggravates this symptom as the eyelid moves over the pterygium.
Dryness
Occurrence: Dryness affects around 40-50% of individuals, particularly those living in dry or windy climates.
Explanation: Pterygium can interfere with the normal distribution of the tear film across the eye, causing areas to become dry. This dryness can further irritate the eye, worsening symptoms like redness and irritation.
Tearing
Occurrence: Excessive tearing is reported by 30-40% of patients.
Explanation: While pterygium can cause dryness, it can also lead to excessive tearing as a reflex response to irritation and dryness. The eye produces more tears to lubricate the surface and alleviate discomfort.
Blurred Vision
Occurrence: Blurred vision affects 20-30% of patients, particularly in advanced stages.
Explanation: As the pterygium grows onto the cornea, it can distort the corneal surface, causing astigmatism or other refractive errors. This distortion leads to blurred or decreased vision, especially if the pterygium extends into the central visual axis. In severe cases, surgery may be required to restore clear vision.
Swelling
Occurrence: Swelling occurs in 10-20% of patients, often alongside other inflammatory symptoms like redness and irritation.
Explanation: Swelling is part of the inflammatory response to the pterygium. The conjunctiva may thicken and swell, particularly during periods of active growth. Swelling can make the eye feel puffy and uncomfortable, especially after exposure to irritants like wind or sunlight.
Discomfort
Occurrence: Discomfort is experienced by 50-60% of patients, ranging from mild to severe depending on the pterygium’s size and stage.
Explanation: Discomfort results from a combination of factors, including irritation, dryness, and the sensation of a foreign body. As the pterygium grows, discomfort can increase, particularly if it becomes inflamed or infected. Environmental factors or prolonged eye use, such as reading or screen time, can exacerbate discomfort.
Light Sensitivity
Occurrence: Light sensitivity, or photophobia, affects 20-30% of individuals, especially those with larger or more advanced pterygium growths.
Explanation: Light sensitivity occurs due to corneal surface disruption and inflammation. The irregular corneal surface scatters light, making the eye more sensitive to bright lights. This symptom is often more pronounced in individuals who spend significant time outdoors in sunny conditions.
Growth on the Eye
Occurrence: The hallmark sign of pterygium is the visible growth on the eye, present in 100% of cases.
Explanation: Pterygium is characterized by a triangular-shaped growth extending from the conjunctiva onto the cornea. It typically appears on the nasal side of the eye but can also occur on the temporal side. While the growth may remain small and asymptomatic in some cases, it can enlarge and cause significant symptoms, including vision impairment.
Diagnostic Evaluation of Pterygium
Pterygium diagnosis is typically made through patient history and a comprehensive eye examination. During the exam, an eye care provider assesses the size, location, and extent of the pterygium. Visual acuity tests are often performed to determine whether the growth affects vision. In some cases, additional diagnostic tests may be required to rule out other conditions or assess the pterygium’s impact on the cornea and surrounding structures. Below are some common diagnostic tests used to evaluate pterygium.
Slit-Lamp Examination
Test Information: A slit-lamp examination is a routine test used to examine the eye’s structures in detail. The patient sits in front of a specialized microscope with a bright light directed into the eye, allowing the healthcare provider to examine the cornea, conjunctiva, and other parts of the eye under high magnification. This test is particularly useful for assessing the pterygium’s size, shape, and location, as well as any associated inflammation or corneal damage.
Results that Indicate Pterygium: A slit-lamp examination reveals the characteristic triangular-shaped growth of a pterygium on the conjunctiva, extending onto the cornea. The provider assesses the growth’s extent and whether it encroaches on the central visual axis. If the pterygium is small and not affecting vision, monitoring may be recommended. However, if it is large or causing significant symptoms, further treatment may be necessary. If the slit-lamp exam does not show a pterygium but symptoms persist, other conditions like pinguecula or conjunctivitis may be considered.
Visual Acuity Test
Test Information: A visual acuity test measures the sharpness of a patient’s vision. The patient reads letters or symbols from a chart at a specific distance, and the results are recorded as a fraction (e.g., 20/20, 20/40). This test helps determine whether the pterygium is affecting vision, particularly if it is growing over the cornea.
Results that Indicate Pterygium: If the visual acuity test shows decreased vision, especially in one eye, it may indicate that the pterygium is affecting the cornea and causing astigmatism or other refractive errors. In such cases, further evaluation and possibly surgical intervention may be recommended to remove the pterygium and restore vision. If the visual acuity test results are normal but symptoms persist, other tests may be needed to rule out alternative causes of vision problems.
Corneal Topography
Test Information: Corneal topography is a specialized imaging test that maps the cornea’s surface curvature. The patient looks into a device that projects rings of light onto the cornea, and a camera captures the reflections, generating a detailed map of the corneal surface. Corneal topography is particularly useful for detecting irregularities caused by pterygium, such as astigmatism.
Results that Indicate Pterygium: Corneal topography results show any distortions in the corneal surface caused by the pterygium. If the pterygium is causing significant astigmatism or other irregularities, the map will reveal areas of steepening or flattening. These findings can guide treatment decisions, especially if the patient experiences blurred vision. If corneal topography results are normal but symptoms persist, other causes of visual disturbances, such as cataracts or keratoconus, may need to be considered.
Conjunctival Biopsy
Test Information: A conjunctival biopsy involves taking a small tissue sample from the conjunctiva for laboratory analysis. This test is typically performed if there is suspicion that the growth may be something other than a benign pterygium, such as a conjunctival tumor. The biopsy is done under local anesthesia, and the tissue sample is sent to a lab for histopathological examination.
Results that Indicate Pterygium: In most cases, biopsy results confirm the diagnosis of pterygium, showing benign fibrovascular tissue. If the biopsy reveals abnormal or malignant cells, further treatment may be necessary, including surgical removal and possibly referral to an oncologist. If the biopsy is negative for pterygium but symptoms persist, other conditions like conjunctival neoplasms or chronic inflammation may need to be investigated.
Ocular Ultrasound
Test Information: Ocular ultrasound uses sound waves to create images of the eye’s internal structures. This test is typically performed if the pterygium is large or if there is concern about deeper involvement of the eye, such as the sclera or underlying tissues. The test is non-invasive and involves placing a small probe on the closed eyelid or directly on the eye after applying a numbing drop.
Results that Indicate Pterygium: Ocular ultrasound shows the extent of the pterygium and whether it has invaded deeper eye structures. In most cases, the ultrasound confirms that the pterygium is confined to the eye’s surface. However, if deeper involvement is detected, more aggressive treatment may be required. If the ultrasound is negative for pterygium but symptoms persist, other conditions like scleritis or episcleritis may need to be considered.
What if All Tests are Negative but Symptoms Persist?
If all tests are negative for pterygium but symptoms continue, follow up with your healthcare provider. Persistent symptoms could indicate another underlying condition, such as dry eye syndrome, allergic conjunctivitis, or another ocular surface disorder. Your provider may recommend additional testing or refer you to a specialist for further evaluation. In some cases, lifestyle changes or environmental modifications may help alleviate symptoms.
Treatment Options for Pterygium
Medications for Pterygium
Artificial Tears
Definition: Artificial tears are over-the-counter eye drops that mimic the eye’s natural moisture, providing lubrication and relief from dryness and irritation.
How and When It’s Used: Often the first line of treatment for mild pterygium, artificial tears help soothe irritation, reduce dryness, and alleviate the gritty sensation associated with the condition. They can be applied multiple times a day as needed.
Expected Outcomes: Patients can expect immediate relief from dryness and irritation. However, artificial tears only manage symptoms and do not address the underlying pterygium itself.
Corticosteroids
Definition: Corticosteroids are anti-inflammatory medications that reduce swelling, redness, and irritation in the eye.
How and When It’s Used: Corticosteroid eye drops are typically prescribed for short-term use in more advanced pterygium cases, particularly when the growth becomes inflamed or swollen. They are not a first-line treatment but are reserved for flare-ups or more severe symptoms.
Expected Outcomes: Patients can expect reduced redness and swelling within a few days to a week. Long-term use is discouraged due to potential side effects, such as increased eye pressure.
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Definition: NSAIDs are medications that reduce inflammation and pain without the use of steroids.
How and When It’s Used: NSAID eye drops may be prescribed when corticosteroids are not suitable. They are commonly used for moderate pterygium cases where inflammation is present but not severe enough to require steroids.
Expected Outcomes: NSAIDs help reduce discomfort and inflammation over several days. They are generally well-tolerated and can be used for longer periods than corticosteroids.
Antihistamines
Definition: Antihistamines reduce allergic reactions, including itching and redness in the eyes.
How and When It’s Used: Antihistamine eye drops may be recommended if pterygium causes allergic-type symptoms like itching or redness. These drops are typically used when there is a clear allergic component to the irritation.
Expected Outcomes: Patients can expect relief from itching and redness within a few days. However, antihistamines do not treat the pterygium itself.
Cyclosporine A
Definition: Cyclosporine A is an immunosuppressive medication used to reduce inflammation and prevent the progression of certain eye conditions.
How and When It’s Used: Cyclosporine A eye drops may be prescribed in chronic or recurrent pterygium cases, especially when inflammation is persistent. It works by modulating the immune response and reducing inflammation over time.
Expected Outcomes: Improvement may take several weeks, but patients often experience reduced inflammation and discomfort with continued use.
Mitomycin C
Definition: Mitomycin C is a chemotherapy agent sometimes used in eye surgery to prevent pterygium recurrence after removal.
How and When It’s Used: Mitomycin C is applied during or after surgery to reduce the risk of regrowth. It is not a first-line treatment but is reserved for cases where surgery is necessary.
Expected Outcomes: Mitomycin C can significantly reduce the likelihood of recurrence after surgery. However, it must be used cautiously due to potential side effects, such as delayed wound healing.
5-Fluorouracil
Definition: 5-Fluorouracil is a chemotherapy drug used to prevent pterygium recurrence following surgery.
How and When It’s Used: Similar to Mitomycin C, 5-Fluorouracil is used during or after excision surgery to minimize regrowth. It is typically reserved for more aggressive or recurrent pterygium cases.
Expected Outcomes: This treatment can lower the risk of recurrence, but like Mitomycin C, it requires careful application to avoid complications.
Topical Antibiotics
Definition: Topical antibiotics are eye drops or ointments used to prevent or treat bacterial infections in the eye.
How and When It’s Used: Topical antibiotics may be prescribed after pterygium surgery to prevent infection. They are not used as a standalone treatment for pterygium but are essential in post-surgical care.
Expected Outcomes: These medications help prevent infection during the healing process, ensuring a smoother recovery.
Lubricating Ointments
Definition: Lubricating ointments are thicker than artificial tears and provide longer-lasting moisture to the eyes.
How and When It’s Used: These ointments are typically used at night to provide extended relief from dryness and irritation. They are often recommended for patients with persistent dryness or discomfort, especially during sleep.
Expected Outcomes: Patients can expect relief from dryness and irritation, particularly overnight, leading to more comfortable mornings.
Beta-Blockers
Definition: Beta-blockers are medications that reduce eye pressure and are commonly used in the treatment of glaucoma.
How and When It’s Used: While not a standard treatment for pterygium, beta-blockers may be prescribed if the condition causes elevated eye pressure or if the patient has coexisting glaucoma.
Expected Outcomes: Beta-blockers help lower eye pressure, reducing the risk of complications in patients with pterygium and glaucoma.
Procedures for Pterygium Treatment
Excision
Definition: Excision is a surgical procedure that involves removing the pterygium from the eye.
How and When It’s Used: Surgical excision is typically reserved for large pterygium cases causing significant discomfort or affecting vision. It is also considered when conservative treatments fail to control symptoms.
Expected Outcomes: Patients can expect immediate removal of the pterygium, with a recovery period of several weeks. However, there is a risk of recurrence, which is why additional measures like grafts or medications may be used.
Conjunctival Autograft
Definition: A conjunctival autograft is a surgical procedure where a small piece of healthy tissue from the patient’s eye is used to cover the area where the pterygium was removed.
How and When It’s Used: This procedure is often performed alongside excision to reduce the risk of recurrence. The healthy tissue helps the eye heal and prevents pterygium regrowth.
Expected Outcomes: The risk of recurrence is significantly lower with a conjunctival autograft compared to excision alone. Recovery typically takes several weeks, and patients can expect improved vision and comfort.
Amniotic Membrane Transplantation
Definition: Amniotic membrane transplantation involves placing a piece of amniotic membrane (from human placental tissue) over the area where the pterygium was removed.
How and When It’s Used: This procedure is used in more severe or recurrent pterygium cases. The amniotic membrane promotes healing and reduces inflammation, helping to prevent recurrence.
Expected Outcomes: Patients can expect a smoother recovery and a lower risk of recurrence compared to excision alone. The healing process may take several weeks.
Improving Pterygium and Seeking Medical Help
While medical treatments are essential for managing pterygium, several home remedies and lifestyle changes can help alleviate symptoms and prevent the condition from worsening. Wearing sunglasses protects your eyes from UV rays, a significant risk factor for pterygium growth. Regular use of artificial tears keeps your eyes moist and reduces irritation. Avoiding wind and dust by wearing protective eyewear or staying indoors during windy conditions can also help. Additionally, using a humidifier in dry environments, consuming omega-3 fatty acids, and staying hydrated support overall eye health.
Telemedicine offers a convenient way to consult with a healthcare provider about your pterygium without needing to visit a clinic. If you’re experiencing persistent discomfort, changes in vision, or worsening symptoms, seek medical advice. Regular eye check-ups are crucial for monitoring the condition, and telemedicine makes it easier to stay on top of your eye health from home.
Living with Pterygium: Tips for Better Quality of Life
Living with pterygium can be challenging, but several strategies can improve your quality of life. Protecting your eyes from environmental irritants like wind, dust, and UV rays is essential. Sunglasses with UV protection and wide-brimmed hats can help shield your eyes. Staying hydrated and using artificial tears regularly can alleviate dryness and irritation. If you spend a lot of time in front of screens, take frequent breaks to reduce eye strain. Finally, attend regular eye check-ups to monitor the condition and adjust your treatment plan as needed.
Conclusion
Pterygium is a common eye condition that can cause discomfort, irritation, and vision problems if left untreated. Early diagnosis and treatment are key to preventing complications and improving your quality of life. Whether through medications, lifestyle changes, or surgery, there are effective options to manage this condition. If you’re experiencing symptoms of pterygium, our telemedicine practice is here to help. Consult with one of our healthcare providers from the comfort of your home to get the care you need.
